Women's health discussion
forums, research news and
women's health issues.
BACK TO...

Aphrodite's Home Page

ARTICLES ABOUT...

Female Sexuality

Relationships

Sexual Dysfunction

Looking Good

STDs

Men

Contraception

Reproductive Health

Conceiving

Pregnancy

Incontinence

Mental Health

Children's Health

Eating Well

Healthy Living

Supplements

Menopause

Weight Issues

Breast Cancer

Custom Search




HELP WITH...

Your Dreams

Personal Development

Counseling By Email

DISCUSSION FORUMS...

Female Sexuality

Trying To Conceive

Surviving Miscarriage

Overcoming Infertility

Reproductive Health

General Health

Contraception

Pregnancy

Parenting

Babies and Toddlers

Relationships

Weddings

Separation and Divorce

Mental Health

Diet & Weight

13 October 2008
Miscarriage prevented with cholesterol drug

Hospital for Special Surgery researchers have found that anti-cholesterol drugs known as statins may be able to prevent miscarriages in women who are suffering from antiphospholipid syndrome (APS). In this autoimmune syndrome, the body produces antibodies directed at phospholipids, the main components of cell membranes.

In low risk pregnancies, APS is associated with a nine-fold increase in miscarriage. In high-risk pregnancies (women who have had at least three prior losses), APS is associated with a 90 percent risk of miscarriage.

"Statins may work as a treatment for women with APS-induced pregnancy complications," said researcher Guillermina Girardi, at the Hospital for Special Surgery in New York. "They are drugs that have been shown to be very safe. There are a lot of women who continue to take statins through pregnancy and the drugs have not been shown to produce birth defects. Statins do not increase the risk of bleeding like anticoagulants, the current treatment for patients with APS."

During pregnancy, women are advised to discontinue most medications, including statins. But Dr. Girardi says that no fetal defects have been reported in women who have continued to use statins while pregnant. The researchers say that careful studies should be conducted to confirm the safety of statins in pregnancy in humans. "Women that are antiphospholipid antibody positive and have a history of previous miscarriages are a good group to perform a clinical trial," Dr. Girardi told the Journal of Clinical Investigation.

The study could also have implications for other conditions. "The study reveals a relationship between tissue factor and PAR2 in inflammation that could have implications for understanding chronic inflammatory conditions such as rheumatoid arthritis," said Dr. Girardi. Tissue factor expression is a characteristic feature of conditions such as sepsis, atherosclerosis, Crohn's disease, and lupus. Finding a way to manipulate tissue factor and PAR2 could lead to treatments for these diseases

Related:
Surviving Miscarriage Discussion Forum
Miscarriage Myths Persist
Miscarriage Risk From Stress In Very Early Pregnancy
Oral Diabetes Drug Shows Promise In Preventing Miscarriage

Source: Hospital for Special Surgery


Home Page     Q & A     Discussion Forums     About Us     Privacy
Your use of this website indicates your agreement to our terms of use.
© 2002 - 2013 Aphrodite Women's Health and its licensors. All rights reserved.